Combined antiretroviral therapy (cART) increases longevity for individuals with HIV infection, by promoting suppression of the virus in plasma. However, some individuals receiving cART therapy present HIV-associated neurocognitive disorder (HAND), low CD4+ count, psychiatric disorders, and /or early dementia. The objective of this study was to evaluate some behavioral and laboratory factors that may be associated with more severe forms of HAND, such as HIV-associated dementia (HAD), mild neurocognitive disorder (MND), and depression, even in adults who use cART and have undetectable plasma viral loads, when compared to adults who have the asymptomatic form (ANI). We found a prevalence of 43.4% in persons with HAD/MND forms. Depression (commonly found in the elderly), low educational level, and discontinuation of treatment were found in HIV+ adults with HAD/MND forms. There was a negative correlation with cognitive impairment vs depression levels (r = -0.65) and CD4+ counts vs depression levels (r = -0.79) in 14 depressed individuals with HAD/MND forms. We conclude that these individuals present cognitive disorders (eg, memory deficits) and/or depression on cART, thereby impairing the activities of daily life, due in part to risk factors emphasized in this study.
INTRODUCTION
HAND (HIV-Associated Neurocognitive Disorder) continues to be a worrisome neurological manifestation in both HIV+ individuals naïve to combined antiretroviral therapy (cART) and on cART (1) . Although antiretrovirals contribute to complete suppression of HIV replication, in order to control disease progression, development and deployment of combination antiretroviral therapy (cART), the ability to monitor the efficacy of cART through the measurement of CD4+ helper T cells in plasma does not always ensure healthy living for adults living with HIV+ (2) , since there have been changes in the pattern of neurocognitive impairments, as well as shift in the severity of deficits, because cognitive impairment can be present in HIV+ subjects, even in the cART era International Annals of Medicine Vol1;1 (8) dementia) was the most common form of HAND and had a negative impact of the patients' quality of life. However, the prevalence of HAD has substantially declined with the advent of cART, making the HAND reduction, although the adults HIV+ longevity can led to an overall increased of the prevalence of more severe forms of HAND, ie, mild neurocognitive disorder form (MND) and HAD (4) . With the shift from the more severe impairments of HAD to milder form of HAND, thus, there were changes in relation to clinical and research focus, with the purpose of avoiding the evolution of the milder form, avoiding worst damages to central nervous system (CNS), because HIV infection is a chronic disease and asymptomatic neurocognitive impairment (ANI) continues to be a compelling diagnostic category in HAND (5) . Knowing that each patient may have a non-standard combination of antiretroviral therapy and that treatment of HAND is predominantly with cART, some antiretroviral drugs may have better penetration into the CNS than other drugs, but it is unclear whether a combination of antiretroviral drugs with better penetration into the CNS has a beneficial impact on neurocognitive performance, or contributes to damage. But, the era difference (pre and cART) in degree of immunosuppression (nadir CD4, especially) is much larger for the drug-asymptomatic-phase than for the other disease stages, and low nadir CD4+ was a robust predictor for neurocognitive impairment (NCI) in both treatment eras (6) . Of all cognitive impairments, problems with learning and memory are reported to a greater extent in the cART era (1, 2, 6) . Clinical characteristics and risk factors for HAND have also changed with cART. Typically, HAND presents executive dysfunction and memory impairment with prominent disruption of attention, multitasking, impulse control, judgement and memory (6) . Although antiretroviral drugs can control infection, there are few studies examining low CD4+ count and HAND in patients who present undetectable viral loads, in the cART era (6) . Additionally, depression is a common condition experienced by people living with chronic diseases that cause disability, which interferes in the recovery of the patient and is considered a potential risk for increased morbidity and mortality, including HIV/AIDS (2, 7) . This neuropsychiatric disease is associated with higher sexual risk behaviors, less adherence to antiretroviral medication and worse clinical outcomes (7) . It can trigger development of cognitive damages relatively early, in adults with this infection (6, 7) . Depression may be the initial presentation of HAD, and may be associated with the progression of cognitive impairment. In addition, patients who demonstrate depression and cognitive impairment together may not respond well to treatment. Depression and cognitive deficits in individuals with HAND, are still an issue that requires further elucidation for the understanding of this psychopathology. Generally, some risk factors are involved in the development of HAND in HIV+ adults, the main factors being: cardiovascular factors (obesity and diabetes) (2, 8) and advanced age (>50 years) (9) . However, some social-behavioral factors may also be involved in HAND. Quality of life and impairment in HIV+ individuals using cART, with suppressed viral loads are neglected, as well as clinical / laboratory follow-up of these subjects, because individuals may present low quality of life, which may also compromise some behavioral factors. The objective of the present study was to analyze some behavioral and laboratory factors that may be associated with severe forms of HAND, which may harm some cognitive domains, as well as be associated with depression in HIV+ adults who use cART and present undetectable plasma viral load.
METHODS

Population
Forty six HIV1-infected individuals (without receiving antidepressant medication, on cART and presenting HIV-1 undetectable plasma viral load, ie, <40 copies/mL), with age range between 22-68 years old were selected by the IHDS test, according to Antinori et al [10] criteria, from a Non-Governmental Organization -GESTOS (Recife, Pernambuco, Brazil). All subjects were informed about the consent and received standardized neurological evaluation. This transversal study was approved by Ethics Committee selected through of the Brazil Platform System (http://aplicacao.saude.gov.br/plataformabrasil/login.j sf-Certificate of Presentation for Ethical Appreciation-CAAE number: 54451116.2.0000.5569). A study that prioritized analysis of individuals without active opportunistic disease and without severe psychiatric disorders. Exclusion criteria: All subjects did not present any comorbidities resulting from opportunistic infections, did not have a history of alcoholism, were non-smokers, were non-users of illicit drugs, had no other psychiatric disorders except depression, had not experienced a cerebral vascular accident, did not have active psychosis, and had not had a head injury with a loss of consciousness.
Laboratory serum analysis
Laboratory tests were processed by Central Laboratory of public health of the state of Pernambuco. Plasma viral load was evaluated by Real Time method HIV1 assay (Abbott®) from 600 µL of plasma (lower and upper limit of quantification, respectively, were of 40-10,000,000 copies/mL). All investigated individuals had undetectable viral loads. CD4+ count was performed by BD FACSCalibur flow cytometer -Multitest™ from 1mL of peripheral blood.
Diagnosis of HAND
Subjects were submitted to a socio-economic questionnaire and neuropsychological assessment (NP) emphasizing cognitive domains in relation to memory, attention, motor speed (upper limbs), as well as assessment of the degree of impairment about activities of daily life, which were used for diagnosing HAND, classified into asymptomatic neurocognitive impairment (ANI), minor neurocognitive disorder (MND) and HIV-associated dementia (HAD) (7) . Especially for adults with HAD, we followed the diagnostic criteria for HIV-associated dementia for abnormalities present in at least two cognitive abilities (11) : Attention and concentration, fast processing of information, reasoning or abstraction, visuospatial ability, memory or learning, language.
International HIV Dementia Scale
The IHDS consists of three items: A timed finger tapping test, a timed alternating HAND sequence test, and a short-term verbal memory test of four items at 2 minutes. The IHDS was originally validated in both a US and sub-Saharan African population (from Uganda). The assessment using IHDS has already been used in our country by other researchers (13) . Tests of neuropsychological assessments for functional decline used in NP, are in detail, in the Table 1 . 
RESULTS AND DISCUSSION
Risk factors
Ten adults were diagnosed with HAD form (9 women and 1 man, age mean 44.5 years, SD± 6.9); 10 people were diagnosed with MND form (6 women and 4 men, Of the 20 individuals with more severe forms of HAND, 14 individuals (70%) presented depression; 10 subjects were classified for the most severe form of HAND (HAD). Some individuals with HAD presented similar responses, when submitted to the Pfeffer's Questionnaire, presenting highlight in questions on "committed social activities", especially regarding question 8 (Remembering appointments, holidays, medications ?), Table 3 . Figure 1B , some overlapping data values.
Fig. 1. Suggestive cognitive deficits, impairment of daily living activities, CD4+ count and depression in people with HAD / MND forms. By Mann Whitney test (A). By Pearson correlation (B, C e D). Note:
The prevalence of more severe forms of HAND in individuals on cART, evaluated in a representative social assistance unit from our region, was of 43.4%, approximately 21% for each form (10/46 HAD and 10/46 MND). In contrast com Heaton et al, the estimated prevalence (excluding severely confounded cases) were 12% for MND and 2% for HAD, and even in patients on cART, there were profound CD4 decline (4) . There was no association among different ages and severe forms of HAND, but we found that level of schooling (not age) is a factor that differentiates HAND strata, especially among illiterate individuals and those who have higher education, considering that there are also different levels of schooling among older individuals. These are factors that lead to nondevelopment of cognitive abilities such as attention and memory. Arentoft et al. (14) examined socioeconomic status (SES) levels across individuals (134 HIV+ adults) by HAND diagnosis (10) . They reveal that SES scores are significantly different across HAND diagnoses and among individuals diagnosed with HAD, it is possible that adults with SES are most vulnerable to the neurocognitive effects of HIV. In our study, according Pfeffer's Functional Assessment Questionnaire, adults with HAD who presented depression demonstrated dissatisfaction with social and individual activities. Only 6.5% (3/46) of individuals with HAND (1 with HAD and 2 with ANI) do not use the antiretrovirals efavirens or zidovudine, because they use other cART (tenofovir, lamivudine, ritonavir or atazanavir). According to studies that evaluated antiretroviral drug-induced depression, individuals who use efavirenz or zidovudine may develop depression in the future (15) . One study reported that efavirenz can cause anxious symptoms, depression, and even suicidal ideation (16) . We found 4 people with severe forms of HAND (HAD= 2; MND= 2) who used efavirens and presented with depression. We identified 6 people with severe forms of HAND (HAD= 3; MND= 3) who use zidovudine in combination with other ART medications and who presented depression. It is also known that low CD4+ T-lymphocyte count and high viral load are risk factors for HAD in untreated HIV infection (17) . However, in our study, severe forms of HAND were found in individuals who received cART and had an undetectable viral load, presenting negative correlation with CD4+ count levels and depression. In some, CD4+ T studies cell count nadir remains strongly associated with HAND, even in virologically suppressed patients on cART. We found a prevalence of 39% (18/46) of depression in adults with HAND (14 with HAD/MND forms and 4 with ANI form). We also found negative correlation between CD4+ count levels of depression, and between cognitive impairment and levels of depression, only in adults with more severe forms of HAND (r= -0.79, 11/14) , suggesting that depression is strongly associated with immunity in these individuals. About typical depression in elderly, one study associated older adults (older than 50 years) who were infected with HIV and geriatric syndromes, they reported that these syndromes are common in adults infected with HIV. The geriatric syndromes assessed included falls, urinary incontinence, functional and mobility impairment, sensory impairment, depression, cognitive impairment, and frailty. The burden of geriatric syndromes is important and will need to be addressed clinically to minimize age related complications for this population (18) . We studied adults who presented a mean age of 46 years; however, we found positive correlation in relation to the impairment of daily life functions (commonly in the elderly) and increased levels of geriatric depression (by GDS test). Altering metabolic patterns, which may lead to endosomal changes (eg, production of amyloid-β peptide), inducing worsening of cognitive functions (19) . Perhaps this mechanism could underlie the association between cognitive impairments (analyzed by MMSE test) and individuals with CDR= 1, when compared to individuals with CDR= 0.5, found in our study. It would be interesting to have studies that include this approach and the profile of the inclusion criteria of our study. A considerable way to decrease the HAND prevalence would be rehabilitation of cognitive functions (considering that individuals who have high schooling have low risk of developing HAD/MND forms), emphasizing memory and motor functions and activities that provide cognitive stimulation. The follow-up of these individuals is a social issue (initially), however, when there are no preventive measures, it becomes a public health issue. Thus, public agencies and non-governmental assistance could promote monitoring these patients, to accomplish scans to identify HAND forms (according neurocognitive tests), favoring an adequate health service to avoid development of the HAD/MND forms or to minimize stages of evolution of these forms, promoting better quality of life for individuals with HIV infection.
CONCLUSION
It is observed that HAND is present strongly even in the cART era, suggesting that the involvement of neurocognitive disorders, in subjects with HIV infection, results from the non-vigilance of monitoring CD4+ cell count, treatment interruption, low education level, onset of depression and inadequate management of antiretroviral drugs. These issues can compromise activities of social and individual daily life, leading to geriatric depression in subjects with HAND (presenting undetectable viral load, CD4+ mean 569.8 cells/μL, using cART that include efavirenz or zidovudine). However, other studies are still needed to investigate associations with molecular science, based on the same inclusion and exclusion criteria of the present study.
